Gaithersburg, MD, United States of America

Ronald Herbst

This inventor holds 14 USPTO granted patents and 14 published patent applications and 4 EPO patents. Top assignees: Medimmune Limited, Boston Pharmaceuticals, Inc., Viela Bio, Inc.. Active years: 2012-2024.

USPTO Granted Patents = 14 (Patent Applications = 14)

% Patents Active = 85.7

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 8.4

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Potomac, MD (US) (2012 - 2014)
Gaithersburg, MD (US) (2018 - 2024)

Company Filing History:

Boston Pharmaceuticals, Inc.

University of Helsinki

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49908 - Bispecific binding proteins and uses thereof (2024-04-09),

2. 11555062 - Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer (2023-01-17),

3. 11529415 - Antibodies specific for IL-21 and uses thereof (2022-12-20),

4. 11279759 - Bispecific binding proteins and uses thereof (2022-03-22),

5. 11104720 - Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit (2021-08-31),

6. 10975155 - CD40L-Fc fusion polypeptides and methods of use thereof (2021-04-13),

7. 10588969 - Antibodies specific for IL-21 and uses thereof (2020-03-17),

8. 10457732 - Bispecific binding proteins and uses thereof (2019-10-29),

9. 10400035 - Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibodies (2019-09-03),

10. 10022443 - Antibodies specific for IL-21 and uses thereof (2018-07-17),

11. 10000553 - CD40L-specific TN3-derived scaffolds and methods of use thereof (2018-06-19),

12. 9896505 - Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease (2018-02-20),

13. 8883992 - Humanized anti-CD19 antibodies (2014-11-11),

14. 8323653 - Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease (2012-12-04),

Title: Inventor Ronald Herbst - Revolutionizing Technology

Introduction: Ronald Herbst, a distinguished inventor hailing from Gaithersburg, MD, has made significant contributions to the field of technology through his innovative creations and patents.

Latest Patents: Ronald Herbst's latest patents include groundbreaking inventions in the realm of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ronald Herbst has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Ronald Herbst has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Ronald Herbst's passion for innovation, coupled with his dedication to creating a positive impact on society through his inventions, solidifies his position as a trailblazing inventor in the world of technology.